Corcept Therapeutics Inc

Connor, Clark & Lunn Investment Management Ltd. CORT

Report date

12/31/2025

Quarter

2025 Q4

Filed

2/10/2026

Shares

221,444

Value ($000)

7,706

Weight

0.0%

2021 Q3 - 2025 Q4 (18 filings)

Shares History

History scope: non-option holdings only (PUT/CALL rows excluded).

All 13F Holders	Filing date	Value ($000s)	% of Holdings	Shares	Reporting period
2025 Q4	2/10/2026	7,706	0.0%	221,444	12/31/2025
2025 Q3	11/13/2025	30,740	0.1%	369,869	9/30/2025
2025 Q2	8/7/2025	23,342	0.1%	318,005	6/30/2025
2025 Q1	5/12/2025	85,804	0.4%	751,218	3/31/2025
2024 Q4	2/10/2025	40,151	0.2%	796,795	12/31/2024
2024 Q3	11/8/2024	39,781	0.2%	859,563	9/30/2024
2024 Q2	8/9/2024	23,265	0.1%	716,056	6/30/2024
2024 Q1	5/9/2024	13,657	0.1%	542,178	3/31/2024
2023 Q4	2/9/2024	11,732	0.1%	361,207	12/31/2023
2023 Q3	11/13/2023	9,875	0.1%	362,436	9/30/2023
2023 Q2	8/10/2023	8,075	0.0%	362,908	6/30/2023
2023 Q1	5/10/2023	4,787	0.0%	221,012	3/31/2023
2022 Q4	2/10/2023	2,818	0.0%	138,743	12/31/2022
2022 Q3	11/10/2022	2,110	0.0%	82,298	9/30/2022
2022 Q2	8/5/2022	1,776	0.0%	74,664	6/30/2022
2022 Q1	5/12/2022	3,098	0.0%	137,550	3/31/2022
2021 Q4	2/10/2022	952	0.0%	48,101	12/31/2021
2021 Q3	11/12/2021	233	0.0%	11,850	9/30/2021